Laddar...
Huperzine A for mild cognitive impairment
BACKGROUND: Mild cognitive impairment (MCI) has been proposed as a condition of intermediate symptomatology between the cognitive changes of ageing and fully developed symptoms of dementia. Treatment in the stages of MCI may delay the deterioration of cognitive impairment and delay the progression t...
Sparad:
| I publikationen: | Cochrane Database Syst Rev |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley & Sons, Ltd
2012
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464949/ https://ncbi.nlm.nih.gov/pubmed/23235666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008827.pub2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|